Data

The GOAL Trial: Comprehensive Geriatric Assessment for Frail Older People with Chronic Kidney Disease to Increase Attainment of Patient-Identified Goals - A Cluster Randomised Controlled Trial

QCIF Dataverse

Dataset description

An investigator-initiated multi-centre, cluster randomised controlled trial that is investigating if Comprehensive Geriatric Assessment (CGA) will allow frail older patients with chronic kidney disease (CKD) to better attain their treatment goals, and if this will benefit their quality of life and care outcomes while being cost-effective. There is an increasing number of frail patients with CKD, and multiple morbidities. Many of them face rapid deterioration of health, referral to residential aged care facilities and loss of independence. This substantively impairs their quality of life and has societal ramifications, including very high costs of care. Patients and carers are often overwhelmed by the multitude of decisions they have to make and may follow a care path that is in contrast to their goals. The GOAL Trial addresses patient-prioritised research topics and outcomes and will be conducted, disseminated and implemented in partnership with patients and their caregivers.

Date Information

Issued from 2026
Click to explore relationships graph
 

Source Study

Trial acronym

Not available

Trial ID

NCT04538157

Funding

Not available

Scientific enquiries

Brief Summary

The GOAL trial addresses patient-prioritised research topics and outcomes and will be conducted, disseminated and implemented in partnership with patients and their caregivers. This will be the first study, internationally, to evaluate the clinical and cost effectiveness of Comprehensive Geriatric Assessment (CGA), a highly promising intervention for improving patient-important health outcomes in frail older people with Chronic Kidney Disease (CKD).

Key Inclusion Criteria

Inclusion Criteria for screening: * Moderate to severe CKD as determined by the treating nephrologist: * Stage 3 = eGFR 30 - 59 ml/min/1.73 m2 * Stage 4 = eGFR 15 - 29 ml/min/1.73 m2 * Stage 5/5D = eGFR below 15 ml/min/1.73m2, including patients receiving dialysis * Aged =65 years, or = 55 years if Aboriginal or Torres Strait Islander For inclusion in enrolment: * Frailty Index >0.25 (FI-CKD tool) Exclusion Criteria: * Estimated life expectancy of less than 12 months. * Unable to provide informe .... Read more

Key Exclusion Criteria
Can healthy volunteers participate?

No

Population

Sample Size    Not Available

Min. age    55 Years

Max. age    N/A

Sex    All

Condition category    Goal Attainment Scaling , Frailty Index

Condition code    Frailty , Chronic Kidney Diseases

Intervention

Intervention code Other interventions - Comprehensive Geriatric Assessment

Comprehensive Geriatric Assessment Experimental Specialist co-ordinated care (known as comprehensive geriatric assessment, or CGA) was developed to address medical, social, mental health, and physical needs with the help of a skilled multi-disciplinary team. Usual Care No intervention Usual Care Other interventions: Comprehensive Geriatric Assessment A CGA is a diagnostic and therapeutic intervention which initially identifies an older person's medical, functional, psychosocial problems and then ....
Read more

Comparison

Control group Not available

Comparison not available.

Outcomes

Not Available

Will the study consider sharing individual participant data?

Yes

What individual participant data might be shared?

STUDY_PROTOCOL,SAP

When can requests for individual participant data be made (start and end dates)?

Beginning 2 years and ending 5 years following main publication. Proposals may be submitted up to 5 years following article publication. After 5 years, the data will be available in our University's data warehouse but without investigator support other than deposited metadata.

Who can request access to individual participant data?

An independent review board will assess proposals based on the following criteria: sound science, benefit-risk balancing and research team expertise.

Where can requests to access individual participant data be made, or data be obtained directly?

_

Source study information is derived from the ClinicalTrials.gov. For more information, please see ClinicalTrials.gov

How is Heath Data Australia supporting health research?

To assist secondary data users in understanding the real-world impact of health and medical research data sharing, the Australian Research Data Commons (ARDC) has created an online guide that outlines a theoretical framework for four key data reuse scenarios. This practical guide was extracted from research papers, and consultation with stakeholders and the research community.

Read the guide

How to access data via Health Data Australia

With Health Data Australia, researchers can explore descriptions of data from our publishing partners, identify relevant datasets, and request access. These requests will then be forwarded to the data owner for review.

To start requesting data, simply login with your AAF account.

Learn more
ACN 633 798 857